CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker? (Q36057445)

11 August 2017

CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker? (English)

1 reference

11 August 2017

Sahar Mahmoud

0 references

Andrew Green

0 references

Ian Ellis

0 references

Andrew Lee

1 reference

11 August 2017

1 May 2012

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

364-365

1 reference

Hallmarks of Cancer: The Next Generation

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

Cancer immunoediting: from immunosurveillance to tumor escape

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382867

Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22737616

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.18614

1 reference

11 August 2017

1 reference

PMC publication ID

3382867

11 August 2017

PubMed publication ID

22737616

1 reference

PMC publication ID

3382867